Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1983 Apr;42(2):142–146. doi: 10.1136/ard.42.2.142

Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis.

R D Armstrong, G S Panayi, K I Welsh
PMCID: PMC1001087  PMID: 6573872

Abstract

Patients with ankylosing spondylitis, psoriatic arthritis, and psoriasis alone were typed for HLA A, B, Cw, and DR antigens, and the antigen frequencies were compared with those in a normal control population and in patients with rheumatoid arthritis. Patients with psoriasis had a significantly raised frequency of Cw6. Those with arthritis in addition to their psoriasis also had raised frequencies of B27 and DR7. Patients with ankylosing spondylitis were characterised by the expected high frequency of HLA B27. Again, those with peripheral arthritis had a higher B27 and DR7 frequency than those without. DR3 is associated with the development of erosions in psoriatic arthritis.

Full text

PDF
142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodmer W. F. The HLA system and disease. The Oliver Sharpey Lecture 1979. J R Coll Physicians Lond. 1980 Jan;14(1):43–50. [PMC free article] [PubMed] [Google Scholar]
  2. Brewerton D. A., Caffrey M., Nicholls A., Walters D., James D. C. HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet. 1974 May 18;1(7864):956–958. doi: 10.1016/s0140-6736(74)91262-8. [DOI] [PubMed] [Google Scholar]
  3. Brewerton D. A., Hart F. D., Nicholls A., Caffrey M., James D. C., Sturrock R. D. Ankylosing spondylitis and HL-A 27. Lancet. 1973 Apr 28;1(7809):904–907. doi: 10.1016/s0140-6736(73)91360-3. [DOI] [PubMed] [Google Scholar]
  4. Dejelo C. L., Braun W. E., Khan M. A., Clough J. D. HLA-DR antigens and ankylosing spondylitis. Transplant Proc. 1978 Dec;10(4):971–972. [PubMed] [Google Scholar]
  5. Espinoza L. R., Vasey F. B., Oh J. H., Wilkinson R., Osterland C. K. Association between HLA-BW38 and peripheral psoriatic arthritis. Arthritis Rheum. 1978 Jan-Feb;21(1):72–75. doi: 10.1002/art.1780210112. [DOI] [PubMed] [Google Scholar]
  6. Green L., Meyers O. L., Gordon W., Briggs B. Arthritis in psoriasis. Ann Rheum Dis. 1981 Aug;40(4):366–369. doi: 10.1136/ard.40.4.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Karvonen J., Lassus A., Sievers U., Tiilikainen A. HL-A antigens in psoriatic arthritis. Ann Clin Res. 1974 Oct;6(5):304–307. [PubMed] [Google Scholar]
  8. Kemple K., Gatti R. A., Leibold W., Klinenberg J., Bluestone R. HLA-D locus typing in ankylosing spondylitis and Reiter's syndrome. Arthritis Rheum. 1979 Apr;22(4):371–375. doi: 10.1002/art.1780220409. [DOI] [PubMed] [Google Scholar]
  9. Krain L. S., Newcomer V. D., Terasaki P. I. HL-A antigen in psoriasis. N Engl J Med. 1973 Jun 7;288(23):1245–1245. doi: 10.1056/nejm197306072882321. [DOI] [PubMed] [Google Scholar]
  10. Metzger A. L., Morris R. I., Bluestone R., Terasaki P. I. HL-A W27 in psoriatic arthropathy. Arthritis Rheum. 1975 Mar-Apr;18(2):111–115. doi: 10.1002/art.1780180203. [DOI] [PubMed] [Google Scholar]
  11. Moll J. M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55–78. doi: 10.1016/0049-0172(73)90035-8. [DOI] [PubMed] [Google Scholar]
  12. Murray C., Mann D. L., Gerber L. N., Barth W., Perlmann S., Decker J. L., Nigra T. P. Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest. 1980 Oct;66(4):670–675. doi: 10.1172/JCI109903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Roux H., Mercier P., Maestracci D., Serratrice G., Sany J., Seignalet J., Serre H. Psoriatic arthritis and HLA antigens. J Rheumatol Suppl. 1977;3:64–65. [PubMed] [Google Scholar]
  15. Schlosstein L., Terasaki P. I., Bluestone R., Pearson C. M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973 Apr 5;288(14):704–706. doi: 10.1056/NEJM197304052881403. [DOI] [PubMed] [Google Scholar]
  16. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978 Apr 20;298(16):869–871. doi: 10.1056/NEJM197804202981602. [DOI] [PubMed] [Google Scholar]
  17. Tiilikainen A., Lassus A., Karvonen J., Vartiainen P., Julin M. Psoriasis and HLA-Cw6. Br J Dermatol. 1980 Feb;102(2):179–184. doi: 10.1111/j.1365-2133.1980.tb05690.x. [DOI] [PubMed] [Google Scholar]
  18. Tsuji K., Inouye H., Nose Y., Sasazuki T., Ozawa A., Ohkido M. Further study on HLA-A, B, C, D, DR and haplotype antigen frequencies in psoriasis vulgaris. Acta Derm Venereol Suppl (Stockh) 1979;87:107–108. [PubMed] [Google Scholar]
  19. White S. H., Newcomer V. D., Mickey M. R., Terasaki P. I. Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med. 1972 Oct 12;287(15):740–743. doi: 10.1056/NEJM197210122871504. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES